NVAX PEER ANALYSIS

Novavax Inc — metric-by-metric comparison with peers and the industry median

NVAXNovavax Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

NVAXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	NVAX	MSB	TLX	CSL	RTALB	Ind. Median
P/E	—	—	—	29.96	4.78●	18.06
P/B	-10.67●	—	6.38	2.24	0.59	3.62
EV/EBITDA	—	—	120.20	10.35●	72.98	15.13
P/S	2.59●	31.30	3.24	2.66	6.52	10.65

Financial Health
Metric	NVAX	MSB	TLX	CSL	RTALB	Ind. Median
Current Ratio	2.48	—	1.43	2.57●	1.21	5.90
Debt/Equity	-203.8%●	—	112.3%	67.4%	1.2%	10.9%
NetDebt/EBITDA	11.76	—	13.13	2.22	0.90●	1.15

Profitability
Metric	NVAX	MSB	TLX	CSL	RTALB	Ind. Median
Net Margin	-14.7%	-115.3%	-0.9%	9.2%	136.3%●	-125.7%
ROE	—	-11.3%	-1.8%	7.7%	15.1%●	-47.5%
ROA	-7.5%	-8.6%	-0.7%	3.8%	13.1%●	-35.8%
EBITDA Margin	-7.1%	-76.6%	3.0%	32.8%●	9.0%	-105.8%

Growth + Dividend
Metric	NVAX	MSB	TLX	CSL	RTALB	Ind. Median
Rev. Growth	-52.5%	410.4%●	56.3%	4.8%	24.0%	5.1%
NI Growth	—	—	—	-39.4%	134.0%●	12.1%
Div. Yield	—	0.0%	—	2.5%●	0.0%	0.2%
Payout	—	0.0%	—	103.1%	0.0%	0.0%

Valuation
Metric	NVAX	GLUE	FTRE	SVRA	VIR	PGEN	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	-10.67●	3.06	3.03	8.93	1.86	85.22	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	2.59	37.23	0.59●	—	23.06	54.58	10.65

Financial Health
Metric	NVAX	GLUE	FTRE	SVRA	VIR	PGEN	Ind. Median
Current Ratio	2.48	9.54	0.95	13.47●	7.11	4.82	5.90
Debt/Equity	-203.8%●	7.5%	212.6%	17.1%	11.8%	485.5%	10.9%
NetDebt/EBITDA	11.76	5.08	-3.45●	1.34	0.86	-0.22	1.15

Profitability
Metric	NVAX	GLUE	FTRE	SVRA	VIR	PGEN	Ind. Median
Net Margin	-14.7%●	-302.7%	-16.5%	—	-676.0%	-647.0%	-125.7%
ROE	—	-32.6%●	-64.5%	-80.0%	-47.7%	—	-47.5%
ROA	-7.5%●	-23.0%	-15.4%	-63.0%	-37.9%	-152.9%	-35.8%
EBITDA Margin	-7.1%●	-287.6%	-10.4%	—	-669.6%	-617.8%	-105.8%

Growth + Dividend
Metric	NVAX	GLUE	FTRE	SVRA	VIR	PGEN	Ind. Median
Rev. Growth	-52.5%	-73.1%	0.9%	-100.0%	214.0%	652.1%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NVAX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.